$OTLK good buy for long term investment

NASDAQ:OTLK   Outlook Therapeutics, Inc.
$OTLK seems to be breaking out upside on the bullish news - reported statistically significant achievement on Phase 3 trial for both Primary and Secondary endpoints!

The chart also shows the double bottom pattern completed with parallel channel formed above it, which is now being broken out upward.

Irregardless where it goes in short term, the company has potential to have 12 years of marketing exclusivity if their BLA get's approved.

Good buy range:
$2.2 - $4

Potential downside - $1.6-$1.8
Price isn't too bad with current estimated global market of $13.1B


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.